In particular, HCK is a hematopoietic cell kinase whose dysregulation may affect microglia (i.e., resident immune cells in the central nervous system playing critical roles in brain immunity, development, and homeostasis) and accelerate early stage Alzheimer's disease-like neuropathology46. Here, HCK is linked to early-onset autosomal dominant Alzheimer disease.